Albinism epidemiology and demographics: Difference between revisions

	Albinism Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Albinism from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Albinism epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Albinism epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Albinism epidemiology and demographics
CDC on Albinism epidemiology and demographics
Albinism epidemiology and demographics in the news
Blogs on Albinism epidemiology and demographics
Directions to Hospitals Treating Albinism
Risk calculators and risk factors for Albinism epidemiology and demographics

Revision as of 14:48, 18 August 2021

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

The prevalence of albinism is estimated to be 1:17,000 to 1:20,000 in the general population ^[1]
In the US, about 18,000 people have albinism
The Prevalence of different types of albinism varies
Oculocutaneous albinism 2 (OCA2) is the most prevalent form
The prevalence of different subtypes are as follows:
- OCA1 occurs in 1:40,000 individuals worldwide; 70% of cases occurs in America and China
- OCA2 occurs in 1:39,000 individuals worldwide; this prevalence is estimated to be 1:10,000 in African Americans, 1:36,000 in overall Americans, and 1:3,900 in Sub-Saharan Africa
- OCA3 occurs in 1: 8500 individuals in Africa
- OCA4 occurs in 1:100,000 individuals; accounts for 24% of Japanese albinism
- OCA5, OCA6, and OCA7 cases are very rare
- Hermansky-Pudlak syndrome (HPS) occurs in 1:500,000 population worldwide; the prevalence of HPS is 1:1800 in Puerto Rico
- Chediak-Higashi syndrome (CHS) is very rare; less than 50 cases were identified in the last 20 years
- Ocular albinism (OA1) occurs in 1:50,000 individuals

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Albinism}}
-{{CMG}}; {{AE}}
+{{CMG}}; {{AE}} {{ S.M}}
-{{PleaseHelp}}
 ==Overview==
 ==Epidemiology and Demographics==
+* The [[prevalence]] of [[albinism]] is estimated to be 1:17,000 to 1:20,000 in the general population <ref> {{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK519018/ |title=Albinism - StatPearls - NCBI Bookshelf |format= |work= |accessdate=}} </ref>
+* In the US, about 18,000 people have [[albinism]]
+* The Prevalence of different types of [[albinism]] varies
+* [[Oculocutaneous albinism]] 2 ([[OCA2]]) is the most prevalent form
+* The prevalence of different subtypes are as follows:
+** OCA1 occurs in 1:40,000 individuals worldwide; 70% of cases occurs in America and China
+** OCA2 occurs in 1:39,000 individuals worldwide; this prevalence is estimated to be 1:10,000 in African Americans, 1:36,000 in overall Americans, and 1:3,900 in Sub-Saharan Africa
+** OCA3 occurs in 1: 8500 individuals in Africa
+** OCA4 occurs in 1:100,000 individuals; accounts for 24% of Japanese albinism
+** OCA5, OCA6, and OCA7 cases are very rare
+** Hermansky-Pudlak syndrome (HPS) occurs in 1:500,000 population worldwide; the prevalence of HPS is 1:1800 in Puerto Rico
+** Chediak-Higashi syndrome (CHS) is very rare; less than 50 cases were identified in the last 20 years
+** Ocular albinism (OA1) occurs in 1:50,000 individuals
 ==References==
 {{Reflist|2}}